D221 Task 1 Practice Improvement Plan for Medication Safety
Phillip December 11, 2025 No Comments

D221 Task 1 Practice Improvement Plan for Medication Safety

D221 Task 1 Practice Improvement Plan for Medication Safety

Name

 Western Governors University

D221 Organizational Systems and Healthcare Transformation

Prof. Name

Date

D221 Task 1 Practice Improvement Plan for Medication Safety

Discuss a System-Level Safety Concern in a Healthcare Setting Using SBAR Format

Situation

Medication administration remains one of the most high-risk responsibilities carried out by bedside nurses, requiring precision, clinical judgment, and strict adherence to verification procedures. These responsibilities encompass accurate dispensing, assessment of drug interactions, monitoring for potential adverse reactions, and compliance with institutional protocols such as dual-nurse verification. Despite these safeguards, medication errors continue to represent a widespread and persistent systems-level threat. Tariq et al. (2023) estimate that between 7,000 and 9,000 preventable deaths in the United States each year can be attributed to medication errors. The impact extends beyond mortality, as thousands of patients experience adverse reactions that may go unreported, contributing to physical harm and emotional distress. These incidents undermine patient trust, increase staff anxiety, and negatively affect the reputation of healthcare organizations. Given these substantial consequences, strengthening medication safety strategies is an essential priority for healthcare systems aiming to preserve quality, safety, and public confidence.

Background

What Data Supports the Need for Change?

Medication errors are among the most frequently documented forms of preventable harm in healthcare environments. According to Grissinger (2019), an estimated 1.5 million individuals in the United States experience medication-related injury annually. The financial implications are equally significant, with acute care facilities incurring at least $3.5 billion in costs solely for the treatment of adverse drug events. When accounting for extended hospital stays, outpatient follow-up care, and decreased patient productivity, national expenditures may exceed $70 billion per year. Approximately 41% of Americans report being affected by a medication error at some point, and roughly 530,000 outpatient medication-related injuries occur annually. These data points reinforce the urgent need for systemic improvements that reduce error rates and strengthen patient safety infrastructures.

What Are the Relevant National Patient Safety Standards?

Nationally recognized patient safety standards—particularly those developed by the Joint Commission—prioritize accurate patient identification and safe medication administration. These standards require nurses to verify identity using at least two reliable identifiers, such as wristbands, medical record numbers, or date of birth, before administering medications. Just as importantly, clinicians must assess allergy history, evaluate potential drug-drug interactions, and ensure that the medication aligns with the clinical order. Adhering to these standards reduces the likelihood of preventable harm and supports consistent, reliable medication processes across the continuum of care.

Assessment

What Is the Impact of Medication Errors on Patients and the Healthcare Setting?

Medication errors significantly affect both patient outcomes and operational performance within healthcare systems. On an individual level, patients may experience adverse drug reactions, prolonged hospitalizations, or long-lasting physical complications. Such events can lead to diminished confidence in the healthcare team and reluctance to seek future medical care. For clinical staff, involvement in a medication error often results in emotional stress, fear of disciplinary action, and a perceived decline in professional credibility. From an organizational perspective, errors contribute to increased legal exposure, financial loss, and impaired institutional reputation. These consequences highlight the multidimensional nature of medication safety and the necessity for system-wide corrective measures.

Impact Areas

Impact Area Description
Patients Increased risk of physical harm, emotional distress, loss of trust in providers
Staff Elevated stress levels, risk of punitive action, reduced morale
Organization Financial burdens, decreased public confidence, heightened legal liability

Recommendation

What Evidence-Based Changes Are Proposed?

The implementation of Electronic Medication Administration Records (eMAR) paired with Barcode Medication Administration (BCMA) represents a highly effective strategy for reducing errors and promoting standardization. These technologies support key principles of high-reliability organizations by improving documentation accuracy, reducing transcription errors, and promoting real-time medication verification. Research by Truitt et al. (2016) demonstrated that integrating eMAR and BCMA technology reduced medication error rates from 0.26% to 0.20%, indicating measurable, positive outcomes. When embedded into routine nursing workflows, these systems provide consistent safeguards that enhance patient safety and ensure compliance with evidence-based practices.

What Barriers Could Hinder Implementation?

Barrier Description
Delays in Emergency Use Rapid medication delivery may be slowed if barcode scanning or system access becomes a bottleneck during urgent situations
Staff Knowledge Deficit Insufficient training and limited familiarity with digital systems can result in user errors and missed safety checks

How Can These Barriers Be Addressed?

Mitigating these barriers requires a multifaceted strategy. First, organizations should establish robust training programs that incorporate hands-on practice, simulation, and periodic competency assessments. Continuous education is essential for maintaining proficiency and ensuring proper system utilization. Second, emergency workflows should be augmented with accessible, fully stocked crash carts and clearly delineated bypass protocols that preserve safety while enabling rapid intervention. Finally, transparent communication regarding system upgrades, process changes, and expected staff responsibilities is necessary to sustain long-term effectiveness and reinforce a culture of safety.

Why Is Shared Decision-Making Important?

Shared decision-making fosters collective ownership of safety initiatives and enhances organizational buy-in. Engaging stakeholders—including nurses, physicians, pharmacists, information technology specialists, and administrative leaders—ensures that diverse perspectives inform the design and rollout of medication safety improvements. This collaborative approach aligns strategic priorities, reinforces compliance, and increases the sustainability of new processes. As noted by the National Institutes of Health (2020), reducing medication errors can prevent significant financial losses, allowing organizations to redirect funds toward staff development, technological advancements, and patient-centered innovations that elevate overall care quality.

Outcome Measurement

Evaluating the effectiveness of eMAR and BCMA implementation relies on monitoring medication error data before and after adoption. A measurable decline in error reports, near misses, and adverse drug events would demonstrate the intervention’s success. Additional indicators—such as staff satisfaction, system utilization rates, and audit compliance—can provide supplementary insights into process reliability and system integration.

Current Care Delivery Model

Many healthcare facilities currently utilize a functional nursing care delivery model, which assigns specific tasks to individual caregivers rather than promoting comprehensive, patient-centered care. Parreira et al. (2021) argue that this model may lead to fragmented communication, inconsistent information exchange, and decreased continuity of care. For instance, laboratory draws are often completed by phlebotomists independent of nursing involvement, resulting in siloed workflows and limited opportunities for coordinated clinical decision-making.

Impact of Recommended Change on Care Delivery Model

Integrating eMAR and BCMA systems into the functional nursing model has the potential to reduce fragmentation by creating unified, electronic pathways for clinical documentation and communication. These technologies centralize medication information, enhance transparency across disciplines, and streamline nursing workflows. As a result, nurses are better equipped to verify orders, communicate effectively with interdisciplinary teams, and deliver safe, consistent care. Ultimately, such improvements may strengthen nurse-patient relationships, decrease medication errors, and enhance the organization’s overall clinical reputation.

Summary Table: SBAR for Medication Safety Concern

SBAR Component Key Points
Situation High prevalence of medication errors; nurses responsible for accurate administration and verification
Background Substantial patient harm and financial costs; national standards emphasize proper identification and safe medication practices
Assessment Errors cause physical and emotional harm, damage trust, elevate staff stress, and create financial and legal consequences
Recommendation Implement eMAR and BCMA; address training needs; ensure emergency readiness; adopt shared decision-making; monitor outcome metrics

References

Grissinger, M. (2019). Medication errors. AMCP. https://www.amcp.org/about/managedcare-pharmacy-101/concepts-managed-care-pharmacy/medication-errors

National Institutes of Health. (2020). Medical errors and patient safety. National Library of Medicine. https://www.ncbi.nlm.nih.gov/

Parreira, P., Santos-Costa, P., Neri, M., Marques, A., Queirós, P., & Salgueiro-Oliveira, A. (2021). Work methods for nursing care delivery. International Journal of Environmental Research and Public Health. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924841/

Tariq, R. A., Scherbak, Y., Sinha, A., & Vashisht, R. (2023). Medication dispensing errors and prevention. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK519065/

Truitt, E., Thompson, R., Blazey-Martin, D., NiSai, D., & Salem, D. (2016). Effect of the implementation of barcode technology and an electronic medication administration record on adverse drug events. Hospital Pharmacy. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911988/

 

error: Content is protected, Contact team if you want Free paper for your class!!